Pulse Biosciences Inc (FRA:6L8)
€ 16.5 -0.2 (-1.2%) Market Cap: 1.13 Bil Enterprise Value: 1.07 Bil PE Ratio: 0 PB Ratio: 13.98 GF Score: 40/100

Q3 2019 Pulse Biosciences Inc Earnings Call Transcript

Nov 07, 2019 / 09:30PM GMT
Release Date Price: €13.14 (+1.52%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Pulse Biosciences' Third Quarter 2019 Investor and Analyst Update Conference Call. As a reminder, this conference call is being recorded. I'd now like to turn the conference over to your host, Brian Dow, Pulse Biosciences Senior Vice President and Chief Financial Officer. Please go ahead.

Brian B. Dow
Pulse Biosciences, Inc. - Executive Officer

Thank you, operator, and good afternoon everyone. Welcome to Pulse Biosciences Quarterly Investor and Analyst Update Call. Joining me on the call today are Darrin Uecker, our President and Chief Executive Officer; and Ed Ebbers, our Executive Vice President and General Manager of Dermatology.

Our comments and responses to your questions during today's call reflect management's views as of today, November 7, 2019, only and will include forward-looking statements. These include statements regarding our plans and expectations relating to regulatory clearance, including the process and expected outcomes, our commercial, operational, scientific, clinical and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot